期刊文献+

碘克沙醇与碘海醇对接受冠脉造影及介入治疗患者肾功能影响的比较 被引量:15

A analysis of the impact if iodixanol and iohexol for coronary angiography on renal function of patients undergoing intervention therapy
暂未订购
导出
摘要 目的探讨等渗性造影剂碘克沙醇及低渗性造影剂碘海醇对接受冠状动脉造影及介入治疗患者肾功能的影响。方法对第107医院心内科收治肾功能不全患者137例的临床资料进行对比分析。根据使用造影剂的不同分为碘克沙醇组67例和碘海醇组70例。检测其术后24、72 h肾功能,与术前肾功能进行统计学分析。结果两组造影术后72 h肾功能差异有统计学意义(P<0.05);两组患者术后24、72 h血清肌酐变化值差异有统计学意义(P<0.05);两组患者术后24 h肌酐水平差异有统计学意义(P<0.05)。结论与碘海醇相比,碘克沙醇在行冠状动脉造影及介入治疗时对肾功能不全患者影响更小。 Objective To explore the impact of isotonic contrat agent iodixanol and hypotonic one iohexol for coronary angiography on the patients with renal insufficiency undergoing intervention therapy. Methods A total of 137 patients with insufficient renal functions,who underwent CAG or PCI in cardiology department of No. 107 of PLA,were enrolled in the study. According to the used contrast agents 137 cases were divided into iodixanol group (67 cases) and iohexol group (70 cases). Before surgery,and at 24 hours,72 hours after surgery renal function was detected,then statistical analysis was taken by using SPSS17.0. Results In the incidence of contrast-induced nephropathy 72 h after operation;in the value change at 24 and 72 hours after operation serum creatinine values and 24 hours after operation in creatinine levels between both groups there was statistical difference (P〈0.05,at all). Conclusion Iodixanol compared with iohexol for coronary angiography and interventional treatment of the patients with renal insufficiency has less impact.
作者 宋福春
机构地区 解放军
出处 《实用医药杂志》 2014年第2期99-101,共3页 Practical Journal of Medicine & Pharmacy
关键词 碘克沙醇 碘海醇 冠脉造影 介入治疗 Iodixanol Iohexol Coronary angiography Intervention therapy
  • 相关文献

参考文献14

  • 1Gurm HS,Dixon SR,Smith DE. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions[J].{H}Journal of the America College of Cardiology,2011,(09):907-914.
  • 2Rihal CS,Christiansen C,Cleary D. Prognostic stratification in critical ill patients with acute renal failure requiring dialysis[J].{H}Archives of Internal Medicine,1995,(14):1505-1511.
  • 3Murphy SW,Barrett BJ,Parfrey PS. Contrast nephrophathy[J].Am Soci Nephrol,2000,(02):177-182.
  • 4倪旭东,陈玉玺.造影剂肾病的发病机制及预防[J].实用医药杂志,2007,24(7):861-862. 被引量:4
  • 5Soma VR,Cavusoglu E,Vidhun R. Contrast-associated Nephropathy[J].{H}Heart Disease,2002,(03):372-379.
  • 6Brenner ZR,Myer SA. Acetylcysteine and nephropathy:An option for high-risk patients receiving intravascular contrast agents[J].Am J Nursing,2003,(06):64AA,64CC-64DD,64FF.
  • 7McCullough PA,Wolyn R,Rocher LL. Acute renal faiure after coronary intervention incidence,risk factors,and relationship to mortality[J].{H}American Journal of Medicine,1997,(05):368-375.
  • 8尤志军,李剑,景建梅(综述),郑敏文(审校).CT增强扫描中对比剂肾病风险管理[J].实用放射学杂志,2011,27(6):953-958. 被引量:17
  • 9Manske CL,Sprafka JM,Strong JT. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography[J].{H}American Journal of Medicine,1990,(06):615-620.
  • 10Fishbane S,Durham JH,Marzo K. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy[J].{H}Journal of the American Society of Nephrology,2004,(02):251-260.

二级参考文献25

  • 1Peter A.Nephrotoxicity and the role of contrast media.Radial Med.2004,22(6):377.
  • 2Liistro F,Falsini G,Bolognese L.The clinical burden of contrast media-induced nephropathy.Ital Heart J.2003,4(10):668.
  • 3Levy EM,Viscoli CM,Horwitz RI.The effect of acute renal failure on mortality:a cohort analysis.JAMA,1996,275:1489.
  • 4Jennifer V.Prevention of radiocontrast-induced nephropathy.Drug Ther Top,2004,33(3):15.
  • 5Radnick MR,Goldfarb S.Contrast media-associated nephrotoxicity.Rev Cardiovasc Med,2003,4(S.5):28.
  • 6Norman EL,Vandana SM.Radiocontrast nephropathy.Curr Interv Card Rep,2000,2(4):335.
  • 7Jennifer V.Prevention of radiocontrast induced nephropathy.Drug Ther Top,2004,33(3):15.
  • 8Pollock DM,Polakowski JS,Wegner CD,et al.Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy.Ren Fail,1997,19(6):753.
  • 9Rees JA,Old SL,Rowlands PC.Contrast-induced nephrotoxicity.Toxicol Pathol,1997,25:158.
  • 10Tervahartiala P,Kivisaari L,Kivisaari R,et al.Nephrotoxicity related to contrast media.Acta Radiol,1993,34:220.

共引文献19

同被引文献143

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33089
  • 2范志清,潘震华,王柏颖,唐玉龙,李华妍.造影剂肾病的研究现状及防治进展[J].齐齐哈尔医学院学报,2007,28(14):1718-1721. 被引量:2
  • 3叶凤,梁海琴,韦勇.老年人使用碘海醇对肾脏损害观察[J].中国热带医学,2007,7(11):2065-2066. 被引量:8
  • 4Jos H, Youn TJ, KH W , et al. Renal toxicity evaluation and comparison between visipaque ( lodixanol ) mad hexabrix ( loxaglate ) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial[J].JACC, 2011, 48 (5): 924.
  • 5Nguyen SA, Suranyi P, Ravene! UJ. Radiation dose at cardiac computed tomography: facts and fiction [J]. J Thorac Imaging, 2010, 25(3): 204-212.
  • 6Manske CL, Sprafka JM, Strong JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography[J]. Am J Med, 1990, 89(6): 615-620.
  • 7Gurm HS, Dixon SR, Smith DE, et al. Renal function based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions [J]. J Am Coil Cardiol, 2011, 58(9): 907-914.
  • 8关建中,李成建,陈炎炎,张玉江.碘海醇不良反应[J].中国误诊学杂志,2008,8(1):247-248. 被引量:17
  • 9Thomsen H S, Stacul F, Webb J A W. Contrast Medium-Induced Nephropathy [ M ]. Contrast Media. Springer Berlin Heidelberg, 2014:81-104.
  • 10Stacul F, Van der Molen A J, Reimer P, et al. Contrast induced ne- phropathy: updated ESU R Contrast Media Safety Committee guidelines [ J ]. Eur Radio1,2011,21 ( 12 ) : 2527-2541.

引证文献15

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部